Keay Nakae
Keay Nakae
billion boston deal management pull rare rhythm scientific seems stops three wants
It seems like Boston Scientific really wants this deal and will pull out all the stops to get it. It's a very rare asset. Cardiac rhythm management has $10 billion and only three companies.
business highly large management profitable rhythm
The cardiac rhythm management business is large -- $10 billion, highly profitable and it's an oligopoly.
hoping number overall people problem revelation wider
The overall number where there is actually a problem is still low, but more importantly, you've got, once again, a revelation that the problem is a little wider than first thought. What people had been hoping to see is some end to this.